Lithium Countertransport and Blood Pressure In CARDIA and TOMHS

This study has been completed.
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00005213
First received: May 25, 2000
Last updated: March 15, 2016
Last verified: June 2000
  Purpose
To conduct ancillary studies of sodium-stimulated lithium counter-transport in the Chicago components of the Coronary Heart Disease Risk Development in Young Adults (CARDIA) cohort and in the Treatment of Mild Hypertension Study (TOMHS) cohort.

Condition
Cardiovascular Diseases
Heart Diseases
Hypertension

Study Type: Observational

Resource links provided by NLM:


Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: March 1988
Study Completion Date: February 1990
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   up to 100 Years   (Child, Adult, Senior)
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria
No eligibility criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

ClinicalTrials.gov Identifier: NCT00005213     History of Changes
Other Study ID Numbers: 1092  R01HL038256 
Study First Received: May 25, 2000
Last Updated: March 15, 2016
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cardiovascular Diseases
Heart Diseases

ClinicalTrials.gov processed this record on July 21, 2016